Number of Participants With Dose Limiting Toxicities (DLTs) Baseline up to Cycle 1 / Day 28 [clinicaltrials_resource:3202eae49be64acb35e130540ff251f4]
Any of the following during first cycle of treatment and attributable to CP-870893:
afebrile Grade (Gr) 4 neutropenia (absolute neutrophil count [ANC] <500 cells/mm^3) ≥7 days or Gr 3 or 4 neutropenia associated with fever (1 oral temperature >38.5 degrees Celsius (C) or 3 oral temperatures >38.0 degrees C in a 24-hour period); Gr 4 thrombocytopenia or Gr 3 thrombocytopenia associated with bleeding; Gr 4 lymphopenia, if coupled with clinical consequence (such as, opportunistic infection) or any other Gr 3 hematological adverse events; ≥Gr 3 non-hematologic toxicities (except alopecia).
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of Participants With Dose Limiting Toxicities (DLTs) Baseline up to Cycle 1 / Day 28 [clinicaltrials_resource:3202eae49be64acb35e130540ff251f4]
Any of the following during first cycle of treatment and attributable to CP-870893:
afebrile Grade (Gr) 4 neutropenia (absolute neutrophil count [ANC] <500 cells/mm^3) ≥7 days or Gr 3 or 4 neutropenia associated with fever (1 oral temperature >38.5 degrees Celsius (C) or 3 oral temperatures >38.0 degrees C in a 24-hour period); Gr 4 thrombocytopenia or Gr 3 thrombocytopenia associated with bleeding; Gr 4 lymphopenia, if coupled with clinical consequence (such as, opportunistic infection) or any other Gr 3 hematological adverse events; ≥Gr 3 non-hematologic toxicities (except alopecia).
Bio2RDF identifier
3202eae49be64acb35e130540ff251f4
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3202eae49be64acb35e130540ff251f4
measure [clinicaltrials_vocabulary:measure]
Number of Participants With Dose Limiting Toxicities (DLTs)
time frame [clinicaltrials_vocabulary:time-frame]
Baseline up to Cycle 1 / Day 28
description
Any of the following during fi ...... toxicities (except alopecia).
identifier
clinicaltrials_resource:3202eae49be64acb35e130540ff251f4
title
Number of Participants With Do ...... aseline up to Cycle 1 / Day 28
@en
type
label
Number of Participants With Do ...... 2eae49be64acb35e130540ff251f4]
@en